BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38406822)

  • 21. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
    Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
    BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?
    Tian T; Huang R; Liu B
    Endocrine; 2019 Jul; 65(1):149-154. PubMed ID: 30924085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma.
    Xiao R; Ni C; Cai Y; Zhou Y; Gong X; Xie K; You J
    Endocrine; 2023 Jun; 80(3):619-629. PubMed ID: 36696026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer.
    Hirsch D; Levy S; Tsvetov G; Weinstein R; Lifshitz A; Singer J; Shraga-Slutzky I; Grozinski-Glasberg S; Shimon I; Benbassat C
    Thyroid; 2010 Oct; 20(10):1179-85. PubMed ID: 20860423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression.
    Na YM; Cho JS; Park MH
    Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of 25(OH)D3, concentration levels in patients with papillary thyroid cancer compared to patients with Hashimoto's thyroiditis].
    Lizis-Kolus K; Hubalewska-Dydejczyk A; Trofimiuk-Muldnerz M; Sowa-Staszczak A; Kowalska A
    Przegl Lek; 2013; 70(11):920-5. PubMed ID: 24697030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
    Miyauchi A; Kudo T; Miya A; Kobayashi K; Ito Y; Takamura Y; Higashiyama T; Fukushima M; Kihara M; Inoue H; Tomoda C; Yabuta T; Masuoka H
    Thyroid; 2011 Jul; 21(7):707-16. PubMed ID: 21649472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined prognostic value of preoperative serum thyrotrophin and thyroid hormone concentration in papillary thyroid cancer.
    Liu Y; Huang Y; Mo G; Zhou T; Hou Q; Shi C; Yu J; Lv Y
    J Clin Lab Anal; 2022 Jul; 36(7):e24503. PubMed ID: 35666615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of hashimoto thyroiditis in papillary thyroid cancer patients and its impact on their Outcome.
    Batool S; Das B; Arif M; Islam N
    J Ayub Med Coll Abbottabad; 2022; 34(2):251-255. PubMed ID: 35576281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal thyrotropin level for low-risk papillary thyroid carcinoma after ultrasound-guided radiofrequency ablation.
    Li X; Yan L; Xiao J; Li Y; Zhu Y; Yang Z; Zhang M; Luo Y
    Int J Hyperthermia; 2023; 40(1):2160880. PubMed ID: 36599433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablation.
    Angell TE; Spencer CA; Rubino BD; Nicoloff JT; LoPresti JS
    Thyroid; 2014 Jul; 24(7):1127-33. PubMed ID: 24697314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-based factors modulating the required thyroxine dose to achieve thyrotropin suppression in intermediate-and high-risk papillary thyroid cancer.
    Zhou RY; Li N; Tan HL; Tang N; Chen P; Liu M; Ou-Yang DJ; Qin ZE; Ai L; Wei B; Zhao YX; Chang S; Huang P
    Front Endocrinol (Lausanne); 2023; 14():1126592. PubMed ID: 37388210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analysis of three novel cell lines derived from human papillary thyroid carcinomas with three different clinical courses.
    Ishikawa M; Tachibana T; Hashimoto H; Toyomura J; Ito T; Tsuboi K; Shibuya K; Hirose T; Minami S; Yoshino G
    Hum Cell; 2014 Jul; 27(3):111-20. PubMed ID: 24567186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
    Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
    Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal Lymphocytic Thyroiditis Nodules Share the Features of Papillary Thyroid Cancer on Ultrasound.
    Hwang S; Shin DY; Kim EK; Yang WI; Byun JW; Lee SJ; Kim G; Im SJ; Lee EJ
    Yonsei Med J; 2015 Sep; 56(5):1338-44. PubMed ID: 26256977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females.
    Choi JH; Lee J; Yang S; Lee EK; Hwangbo Y; Kim J
    Sci Rep; 2018 Oct; 8(1):15004. PubMed ID: 30301923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity to thyroid hormone indices are associated with papillary thyroid carcinoma in Chinese patients with thyroid nodules.
    Sun J; Liu J; Wu TT; Gu ZY; Zhang XW
    BMC Endocr Disord; 2023 Jun; 23(1):126. PubMed ID: 37264363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body mass index and weight gain after middle adulthood are associated with risk of papillary thyroid cancer: A case-control study.
    Hu MJ; Zhao HH; Li GA; Zhang HS; He JL; Huang F
    Cancer Epidemiol; 2021 Dec; 75():102039. PubMed ID: 34562748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.
    Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A
    PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.